Department of Medical Sciences, School of Veterinary Medicine, Madison 53706.
Department of Animal Science, University of Wisconsin, Madison 53706.
J Dairy Sci. 2018 Aug;101(8):7375-7382. doi: 10.3168/jds.2017-14270. Epub 2018 May 16.
The primary objective of this randomized controlled trial was to determine whether anti-IL-10 egg yolk antibodies fed upon arrival to a calf ranch would lower the prevalence of Cryptosporidium parvum shedding in naturally challenged preweaned dairy calves. The secondary objectives included measuring the effect of anti-IL-10 antibodies on calf health, performance, and shedding of less common diarrheal pathogens. A total of 133 calves, enrolled at 24 to 72 h of age, received a daily dose of 0.96 g of egg yolk powder with anti-IL-10 antibodies (MAB, n = 71) or without anti-IL-10 antibodies (MEP, n = 62) split between 2 feedings for the first 11 d on feed at a calf ranch. Daily health evaluations were completed for 15 d after arrival and on d 56. Digital weights were collected at enrollment and d 56, and hipometer weights were collected at enrollment and d 7 and 56. Packed cell volume and serum total protein concentration were measured at enrollment and on d 7 and 14. Fecal pH was measured at enrollment and on d 5 and 14, and fecal pathogen (C. parvum, coronavirus, rotavirus, and Salmonella spp.) shedding was assessed at d 5 and 14. Continuous outcomes were compared between groups using a Student's t-test or Wilcoxon rank sum test. Fecal pathogen shedding at d 14, respiratory disease at d 56, and antibiotic usage were compared using relative risk (RR) and chi-squared test. Fecal pH (median and interquartile range) on d 14 was 6.65 (6.39-6.99) and 6.52 (5.97-6.81) for MAB and MEP, respectively. On d 56, the risk of respiratory disease was lower for MAB compared with MEP (RR = 0.40; confidence interval = 0.16-0.99). The risk for antibiotic treatment was lower for MAB- compared with MEP-treated calves (RR = 0.38; confidence interval = 0.17-0.88). The risk of shedding rotavirus was higher in MAB (RR = 1.38; confidence interval = 1.10-1.81) calves. After multivariable analyses, hipometer weights (least squares means ± standard error) were 1.7 ± 0.8 kg greater on d 56 in MAB compared with MEP; however, ADG was 0.04 ± 0.02 kg/d lower in MAB calves. Total health score, diarrhea days, average respiratory score, packed cell volume, and serum total protein were not affected by feeding anti-IL-10 egg antibodies. In summary, feeding anti-IL-10 antibodies was associated with increased fecal pH, reduced risk of respiratory disease later in the preweaning period, and decreased antibiotic usage despite higher rotavirus infection. These findings might be associated with improved mucosal immunity, enhanced host defenses, or reduced susceptibility and warrant further investigation.
本随机对照试验的主要目的是确定在小牛牧场到达时给予抗白细胞介素-10 卵黄抗体是否会降低自然感染的未断奶奶牛犊牛粪便中隐孢子虫细小病毒脱落的流行率。次要目标包括测量抗白细胞介素-10 抗体对小牛健康、性能和较少见的腹泻病原体脱落的影响。共 133 头小牛,在出生后 24 至 72 小时登记,在小牛牧场的前 11 天,每天接受 0.96 克含抗白细胞介素-10 抗体的卵黄粉(MAB,n=71)或不含抗白细胞介素-10 抗体的卵黄粉(MEP,n=62),在 2 次喂食中分开。到达后 15 天和第 56 天完成每日健康评估。在登记时和第 56 天收集数字体重,在登记时和第 7 天和第 56 天收集髋骨计体重。在登记时和第 7 天和第 14 天测量红细胞压积和血清总蛋白浓度。在登记时和第 5 天和第 14 天测量粪便 pH 值,并在第 5 天和第 14 天评估粪便病原体(隐孢子虫、冠状病毒、轮状病毒和沙门氏菌属)脱落情况。使用学生 t 检验或 Wilcoxon 秩和检验比较组间连续结果。使用相对风险(RR)和卡方检验比较第 14 天粪便病原体脱落、第 56 天呼吸道疾病和抗生素使用情况。MAB 和 MEP 的粪便 pH 值(中位数和四分位距)分别为第 14 天的 6.65(6.39-6.99)和 6.52(5.97-6.81)。第 56 天,与 MEP 相比,MAB 治疗的小牛患呼吸道疾病的风险较低(RR=0.40;置信区间=0.16-0.99)。与 MEP 治疗的小牛相比,MAB 治疗的小牛接受抗生素治疗的风险较低(RR=0.38;置信区间=0.17-0.88)。MAB 治疗的小牛轮状病毒脱落的风险更高(RR=1.38;置信区间=1.10-1.81)。在多变量分析后,MAB 组第 56 天的髋骨计体重(最小二乘均数±标准误差)比 MEP 组高 1.7±0.8 公斤;然而,MAB 组的 ADG 比 MEP 组低 0.04±0.02 kg/d。总健康评分、腹泻天数、平均呼吸道评分、红细胞压积和血清总蛋白不受喂食抗白细胞介素-10 卵黄抗体的影响。总之,给予抗白细胞介素-10 抗体与粪便 pH 值升高、未断奶期后期呼吸道疾病风险降低以及抗生素使用减少有关,尽管轮状病毒感染增加。这些发现可能与改善黏膜免疫、增强宿主防御能力或降低易感性有关,值得进一步研究。